Search

Your search keyword '"P, Treffel"' showing total 70 results

Search Constraints

Start Over You searched for: Author "P, Treffel" Remove constraint Author: "P, Treffel"
70 results on '"P, Treffel"'

Search Results

1. Case report: A laser and radiofrequency ablation in a laryngeal chondrosarcoma.

6. Organization and Operation of Documentation and Information Centres in Teaching Establishments

8. Une maladie veino-occlusive pulmonaire familiale avec mutation biallélique hétérozygote composite d’EIF2AK4

9. Néphrite tubulo-interstitielle et maladie de Crohn, néphrotoxicité ou atteinte extradigestive de la maladie de Crohn ? À propos d'un cas.

10. Denosumab-treated Giant Cell Tumors of Bone: A Clinicopathologic Analysis of 35 Cases From the French Group of Bone Pathology

11. Barrier function of the skin in a repetitive irritation model and influence of 2 different treatments

12. Bioengineering measurements of barrier creams efficacy against toluene and NaOH in an in vivo single irritation test

13. Dermatopharmacology of Topical Preparations : A Product Development-Oriented Approach

14. Hydration, transepidermal water loss, pH and skin surface parameters: correlations and variations between dominant and non-dominant forearms

15. Contents, Vol. 6,1993

16. High-performance liquid chromatographic determination of citropten and bergapten in suction blister fluid after solar product application in humans

17. Citropten and Bergapten Suction Blister Fluid Concentrations after Solar Product Application in Man

18. Jugular and Portal Vein Volume, Middle Cerebral Vein Velocity, and Intracranial Pressure in Dry Immersion.

20. Correlation of in vitro and in vivo testing

22. Measurement of sodium lauryl sulfate-induced skin irritation

23. Skin penetration and sun protection factor of ultra-violet filters from two vehicles

24. Emollients and photo(chemo)therapy: a call for caution

25. Irritant reactions on hairless micropig skin: a model for testing barrier creams?

26. Stratum corneum dynamic function measurements after moisturizer or irritant application

27. Surface recovery and stripping methods to quantify percutaneous absorption of caffeine in humans

28. Ibuprofen epidermal levels after topical application in vitro: effect of formulation, application time, dose variation and occlusion

29. Effect of pressure on in vitro percutaneous absorption of caffeine

30. Feasibility of measuring the bioavailability of topical ibuprofen in commercial formulations using drug content in epidermis and a methyl nicotinate skin inflammation assay

31. A new micronized 5-methoxypsoralen preparation. Higher bioavailability and lower UVA dose requirement

32. Transepidermal water loss related to volar forearm sites in humans

33. Effect of occlusion on in vitro percutaneous absorption of two compounds with different physicochemical properties

34. Use of a surface recovery technique to evaluate percutaneous absorption of 5-methoxypsoralen in humans

35. Peak blistering point: influence on fluid levels of 5-MOP in human skin in vivo after systemic administration

36. Chronopharmacokinetics of 5-methoxypsoralen

37. Endothelial Cell Hypertrophy and Microvascular Proliferation in Meningiomas Are Correlated with Higher Histological Grade and Shorter Progression-Free Survival.

38. Évaluation de l’impact de la mise en place d’une consultation d’urgence oncologique thoracique sur les délais de prise en charge au cours de la pandémie de COVID-19

39. Répartition et facteurs pronostiques de l’addiction oncogénique dans l’adénocarcinome bronchopulmonaire métastatique : une étude rétrospective monocentrique au CHRU de Nancy

40. Surface Recovery and Stripping Methods to Quantify Percutaneous Absorption of Caffeine in Humans

41. Pain and Vertebral Dysfunction in Dry Immersion: A Model of Microgravity Simulation Different from Bed Rest Studies

42. Measurement of sodium lauryl sulfate-induced skin irritation.

43. Emollients and photo(chemo)therapy: a call for caution.

44. Evaluation of barrier creams: an in vitro technique on human skin.

45. Ibuprofen epidermal levels after topical application in vitro: effect of formulation, application time, dose variation and occlusion.

46. Effect of pressure on in vitro percutaneous absorption of caffeine.

47. Feasibility of measuring the bioavailability of topical ibuprofen in commercial formulations using drug content in epidermis and a methyl nicotinate skin inflammation assay.

48. Transepidermal water loss related to volar forearm sites in humans.

49. A new micronized 5-methoxypsoralen preparation. Higher bioavailability and lower UVA dose requirement.

50. Effect of occlusion on in vitro percutaneous absorption of two compounds with different physicochemical properties.

Catalog

Books, media, physical & digital resources